000 | 01674 a2200505 4500 | ||
---|---|---|---|
005 | 20250514073245.0 | ||
264 | 0 | _c20040713 | |
008 | 200407s 0 0 eng d | ||
022 | _a0012-186X | ||
024 | 7 |
_a10.1007/s00125-003-1170-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLopes, C | |
245 | 0 | 0 |
_aPAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population. _h[electronic resource] |
260 |
_bDiabetologia _cSep 2003 |
||
300 |
_a1284-90 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aBody Mass Index |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aCoronary Disease _xepidemiology |
650 | 0 | 4 |
_aDiabetes Mellitus _xblood |
650 | 0 | 4 |
_aDiabetic Angiopathies _xepidemiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFrance |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInsulin _xblood |
650 | 0 | 4 | _aInsulin Secretion |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMetabolic Syndrome _xgenetics |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aObesity |
650 | 0 | 4 | _aPedigree |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xgenetics |
650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
650 | 0 | 4 |
_aTriglycerides _xblood |
650 | 0 | 4 |
_aWhite People _xgenetics |
700 | 1 | _aDina, C | |
700 | 1 | _aDurand, E | |
700 | 1 | _aFroguel, P | |
773 | 0 |
_tDiabetologia _gvol. 46 _gno. 9 _gp. 1284-90 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00125-003-1170-0 _zAvailable from publisher's website |
999 |
_c12636518 _d12636518 |